Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm®
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

SPOT ON
Monkeypox in Europe

PHARMACEUTICAL SUPPLY
Supply shortage of relevant thrombolytics like alteplase (ACTILYSE): How could this happen?

THERAPY FROM A CRITICAL VIEWPOINT
Nirmatrelvir plus ritonavir (PAXLOVID) and molnupiravir (LAGEVRIO): observational data regarding omicron
Sexually transmitted Chlamydia infections: azithromycin no longer treatment of choice

a-t READERS QUESTIONS AND COMMENTS
IMMUNOBON – a supplementary balanced diet against hayfever?
Off label use of the anti-alcoholism drug disulfiram (ANTABUS, no longer marketed) against Lyme borreliosis?

IN BRIEF
Rucaparib (RUBRACA) – mislead by a surrogate endpoint

SIDE EFFECTS
Myocarditis/pericarditis with the protein-based SARS-CoV-2 vaccine NVX-CoV2373 (NUVAXOVID)  free article 
© 2024 arznei-telegramm